Skip to main content

Devices and technology

Artificial pancreas systems

12-14-2018 | Artificial pancreas systems | News

MD-Logic closed-loop system successful for unmonitored day and night use

The DREAM5 randomized trial has confirmed the efficacy of closed-loop insulin delivery with the MD-logic algorithm in adolescents and young adults without remote monitoring.


Diabetes Obes Metab 2018; doi:10.1111/dom.13585

12-14-2018 | Risk factors | Feature | Article

Sleep duration: Waking up to a major metabolic risk factor

The effect of sleep duration on glucose regulation and cardiometabolic risk is becoming an increasingly high-profile issue. medwireNews takes a look at the latest evidence, which shows the gravity of the problem but also offers some solutions.

10-04-2018 | Artificial pancreas systems | EASD 2018 | News

‘Gold standard’ trial tests closed-loop delivery across the age spectrum

A randomized trial demonstrates the efficacy of closed-loop insulin delivery in a wide range of patients with poorly controlled type 1 diabetes.


Lancet 2018; doi:10.1016/S0140-6736(18)31947-0
Lancet 2018; doi:10.1016/S0140-6736(18)32329-8
EASD Annual Meeting; Berlin, Germany: 1–5 October 2018

08-29-2018 | Insulin pumps | Review | Article

Advances in closed-loop insulin delivery systems in patients with type 1 diabetes

Dadlani V et al. Curr Diab Rep 2018; 18: 88. doi: 10.1007/s11892-018-1051-z

07-24-2018 | Devices and technology | Editorial | Article

The right device at the right time: Optimizing the benefit

Advisory Board member Katharine Barnard scrutinizes the opinion that clinicians should be relying on glycemic outcomes when weighing the decision to prescribe a diabetes device.

Katharine Barnard

06-26-2018 | Devices and technology | Review | Article

Technology in the management of type 1 diabetes mellitus: Current status and future prospects

Tauschmann M Hovorka R. Nat Rev Rheumatol 2018. doi: 10.1038/s41574-018-0044-y

07-10-2018 | Artificial pancreas systems | ADA 2018 | News

OpenAPS user glycemic data reported

Patients with type 1 diabetes who move to a DIY closed-loop insulin delivery system have significant improvements in their glycemic control, shows an analysis of continuous glucose monitoring data.


ADA 2018; Orlando, Florida, USA: 22–26 June

07-02-2018 | Artificial pancreas systems | ADA 2018 | News

Real-world MiniMed data in line with trial findings

Patients using the MiniMed 670G hybrid closed-loop system in the real world achieve similar glycemic control to patients who used it in the pivotal clinical trial, researchers have reported.


ADA 2018; Orlando, Florida, USA: 22–26 June

06-26-2018 | Artificial pancreas systems | Highlight | News

Closed-loop delivery improves inpatient glucose control in type 2 diabetes

Fully closed-loop insulin delivery results in a markedly improved time in range among inpatients with type 2 diabetes receiving noncritical care, researchers have reported.


N Engl J Med 2018; Advance online publication

05-10-2018 | Devices and technology | Review | Article

Diabetes care in the digital era: A synoptic overview

Fatehi F, Menon A, Bird D. Curr Diab Rep 2018; 18: 38. doi: 10.1007/s11892-018-1013-5

05-16-2018 | Artificial pancreas systems | News

Glucagon in closed-loop system guards against exercise-induced hypoglycemia

Using a dual-hormone closed-loop insulin delivery system that detects when the wearer is doing exercise results in a low rate of exercise-induced hypoglycemia, show findings from a small randomized study.


Diabetes Care 2018; Advance online publication

04-18-2018 | Artificial pancreas systems | Article

Artificial pancreas treatment for outpatients with type 1 diabetes: Systematic review and meta-analysis

Bekiari E et al. BMJ 2018; 361: k1310. doi: 10.1136/bmj.k1310 

04-18-2018 | Artificial pancreas systems | News

Data support artificial pancreas for type 1 diabetes, but better evidence needed

Analysis of the research to date comparing artificial pancreas treatment with other insulin systems supports its ability to significantly improve glycemic control in patients with type 1 diabetes, while reducing the burden of hypoglycemia.


BMJ 2018; 361: k1310, k1613

03-27-2018 | Pregnancy | News

Closed-loop insulin delivery shows promise in pregnancy

A small study suggests that closed-loop insulin delivery can produce equivalent glycemic control to that of sensor-augmented pump delivery, but with less hypoglycemia, during 1 month of use by pregnant women with type 1 diabetes.


Diabetes Care 2018; Advance online publication

09-28-2017 | Type 1 diabetes | Book chapter | Article

Type 1 diabetes mellitus and exercise

Roberts AJ et al. In: Diabetes and Exercise. Edited by Reusch JEB et al. Springer International Publishing AG, 2018. doi: 10.1007/978-3-319-61013-9_19

08-15-2017 | Artificial pancreas systems | Review | Article

Multivariable adaptive artificial pancreas system in type 1 diabetes

Cinar A. Curr Diab Rep 2017; 17: 88. doi: 10.1007/s11892-017-0920-1

09-08-2017 | Artificial pancreas systems | News

News in brief

Artificial pancreas stands up to intensive winter sports

Adolescents with type 1 diabetes attending a ski camp achieved better glycemic control with closed-loop control than with a sensor-augmented insulin pump, researchers report.

05-13-2017 | Devices and technology | Review | Article

A review of the current challenges associated with the development of an artificial pancreas by a double subcutaneous approach

Christiansen SC et al. Diabetes Ther 2017; 8: 489–506. doi: 10.1007/s13300-017-0263-6

05-24-2017 | Artificial pancreas systems | News

Meta-analysis supports artificial pancreas superiority over pumps

Artificial pancreas systems increase time in blood glucose target range by nearly 3 hours per day compared with conventional pump therapy in outpatients with type 1 diabetes, meta-analysis data show.


Lancet Diabetes Endocrinol 2017; Advance online publication

Interactive patient case study

12-21-2018 | Hypoglycemia | Case study

Hypoglycemia and technology

Develop and test your knowledge on the use of different technologies to reduce hypoglycemia risk through this practical example and self-assessment authored by Riccardo Bonfanti and Francesco Chiarelli. This 15 minutes case presents the identification of problematic hypoglycemia and the appropriate use and monitoring of different technologies in the context of reducing the occurrence and risk of hypoglycemia.

image credits